Aims & Scope ::: Clinical Immunology, Endocrine & Metabolic Drugs

ISSN: 2212-7089 (Online)
ISSN: 2212-7070 (Print)


Volume 1, 2 Issues, 2014






Clinical Immunology, Endocrine & Metabolic Drugs

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Emilio Jirillo
Professor of Immunology, University of Bari
Bari
Italy


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Aims & Scope

Clinical Immunology, Endocrine & Metabolic Drugspublishes original research, expert reviews, drug clinical trials and thematic issues in all core areas of translational and clinical immunology, endocrine & metabolic drug research.

The journal publishes pre-clinical and clinical studies on the development of new immunology, endocrine & metabolic agents. Clinical studies of new reported immunology, endocrine & metabolic drugs include Phase 1 - IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinicians, toxicologists, medicinal chemists, and pharmacologists.

Advertisement

Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science